In contrast, the results for plasma bFGF levels are conflicting and both normal and increased plasma levels have been described for patients with untreated AML, but none of these studies have described any prognostic impact of bFGF levels (61–63). The gene discussed is FGF2; the disease is acute myeloid leukemia.